The earnings call highlighted strong financial performance with significant growth in EBITDA, cash flow, and NICU volumes, as well as successful cost management and portfolio restructuring. However, challenges include revenue decline in non-same unit activities and potential headwinds from new legislation. The company remains optimistic about managing these challenges.

Company Guidance

During the Q2 2025 earnings conference call for Pediatrix Medical Group, the company provided optimistic guidance based on several key metrics. The adjusted EBITDA for the second quarter was reported at over $73 million, which exceeded expectations, driven by a same-unit revenue growth of over 6%. This growth resulted from increased hospital-based volume, particularly with NICU days up by 6%, alongside favorable reimbursement factors and strong revenue cycle management (RCM) collections. The company raised its full-year adjusted EBITDA range to $245 million to $255 million, reflecting confidence in continued performance. Despite a 7% decrease in consolidated revenue due to portfolio restructuring, same-unit pricing rose by 3.5%, influenced by increased patient acuity and higher contract administrative fees. The company also noted a decrease in SW&B expenses due to restructuring, although same-unit expenses saw a moderate rise due to incentive compensation. The call highlighted a strong cash flow generation of $138 million, ending the quarter with $225 million in cash and a net debt of just over $380 million, resulting in a net leverage ratio of above 1.5x. The outlook for the second half of 2025 was optimistic, with adjusted EBITDA expected to be consistent across the third and fourth quarters.

Exceeded Expectations with Strong EBITDA

Adjusted EBITDA of over $73 million exceeded expectations, driven by over 6% growth in same unit revenue and strong hospital-based volume.

Increased Cash Flow and Improved Cash Position

Operating cash flow increased to $138 million from $109 million in the prior year, with a cash balance ending at $225 million.

Reduction in Expenses and Improved Efficiency

Decreased G&A expenses due to staffing reductions and modest decreases in other expense categories, contributing to a decline in D&A expenses.

NICU Volume Growth

NICU days up over 6%, driven by strong hospital-based service volumes.

Successful Portfolio Restructuring

Portfolio restructuring led to a decrease in non-same unit activity but was offset by strong same-unit growth.

Pediatrix Medical Group (MD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	0.47 / -	0.44	―	―	―
Jun 30, 2025	2025 (Q2)	0.42 / 0.53	0.34	55.88% (+0.19)	―	―
May 06, 2025	2025 (Q1)	0.24 / 0.33	0.2	65.00% (+0.13)	―
Feb 20, 2025	2024 (Q4)	0.37 / 0.51	0.32	59.38% (+0.19)	―
Nov 01, 2024	2024 (Q3)	0.37 / 0.44	0.32	37.50% (+0.12)	―
Aug 06, 2024	2024 (Q2)	0.31 / 0.34	0.39	-12.82% (-0.05)	―
May 07, 2024	2024 (Q1)	0.18 / 0.20	0.23	-13.04% (-0.03)	―
Feb 20, 2024	2023 (Q4)	0.33 / 0.32	0.47	-31.91% (-0.15)	―
Nov 02, 2023	2023 (Q3)	0.43 / 0.32	0.4	-20.00% (-0.08)	―
Aug 03, 2023	2023 (Q2)	0.40 / 0.39	0.47	-17.02% (-0.08)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jun 30, 2025	$14.03	$14.35	+2.28%
May 06, 2025	$12.95	$14.48	+11.81%
Feb 20, 2025	$14.11	$17.23	+22.11%
Nov 01, 2024	$12.32	$15.21	+23.46%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Pediatrix Medical Group (MD) report earnings?

Pediatrix Medical Group (MD) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).

What is Pediatrix Medical Group (MD) earnings time?

Pediatrix Medical Group (MD) earnings time is at Oct 30, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MD EPS forecast?

MD EPS forecast for the fiscal quarter 2025 (Q3) is 0.47.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing